A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma

Trial Details

NCT ID

NCT06321250

Phase

PHASE1

Sponsor

Jemincare

Status

RECRUITING

Cancer Type

Kidney Cancer

Interventions

• JMKX003948

Locations (sample)

• Beijing, China|39.9075,116.39723

Key Eligibility Criteria

• Has the ability to understand and willingness to sign a written informed consent form.
• Male or female from 18 years of age or older.
• Histologically confirmed locally advanced or metastasis clear cell renal cell carcinoma.
• Has at least one measurable lesion per RECIST v1.1.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.